Re: ‘Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis’
The article by Bergamini et al. [1] adds to the growing body of evidence supporting surveillance, rather than adjuvant chemotherapy, in the postoperative management of ovarian immature teratomas (IT). Postop surveillance is established for paediatric IT [2–5] yet international guidelines continue to recommend adjuvant chem otherapy for nearly all adults [6,7]. The authors highlight studies suggesting that postoperative surveillance may also be safe for adult patients [8], particularly in stage I disease [9], but rightly point out that clinical evidence is extremely sparse.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Michelle Lockley, Sara Stoneham, Jonathan Shamash, Farzana Pashankar, Lindsay Frazier Tags: Letter to the Editor Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Immature Teratoma | Ovarian Cancer | Ovaries | Pediatrics | Study | Teratoma